Long-Term Functional and Anatomical Outcome after Descemet Stripping Automated Endothelial Keratoplasty: A Prospective Single-Center Study
Table 2
Ophthalmic and anatomical outcomes (means ± SD) and the number of eyes (n) that were assessed at baseline and during follow-up.
Baseline
1 month
3 months
6 months
1 year
2 years
3 years
5 years
7 years
BSCVA (logMAR)
0.48 ± 0.27
0.33 ± 0.18
0.26 ± 0.17
0.21 ± 0.13
0.18 ± 0.13
0.17 ± 0.16
0.15 ± 0.14
0.19 ± 0.26
0.18 ± 0.20
Straylight (log(s))
1.53 ± 0.22 (60)a
1.40 ± 0.24 (26)
1.44 ± 0.24 (31)
1.40 ± 0.17 (34)
1.41 ± 0.15 (51)
1.38 ± 0.25 (73)
1.43 ± 0.17 (91)
1.44 ± 0.21 (82)
1.45 ± 0.19 (24)
Graft ECD (cells/mm2)
2736 ± 153
1837 ± 567
1929 ± 583
1864 ± 521
1783 ± 609
1672 ± 552
1501 ± 607
1237 ± 524
1058 ± 587
Corneal thickness (μm)
683 ± 95
595 ± 50
592 ± 50
592 ± 47
589 ± 46
588 ± 46
587 ± 48
610 ± 87
617 ± 58
SD: standard deviation; BSCVA: best spectacle corrected visual acuity; ECD: endothelial cell density. aIn parentheses, the number of eyes for which straylight measurements were attempted.
